NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

NCT05965908

CompletedPhase 3

Sponsor: Beni-Suef University

Conditions: Polycystic Ovary

Interventions: liraglutide, Metformin

Countries: Egypt

The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and liraglutide in infertile women with PCOs.

Eligibility overview

Sex: FEMALE

Age: 15 Years to 45 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* 15-45 years\\
* Poly cystic ovary syndrome based on the Rotterdam criteria

Exclusion Criteria:

1. congenital adrenal hyperplasia,
2. poorly controlled thyroid disease
3. Taking antidiabetic drugs which can affect insulin resistance
4. chronic kidney disease
5. liver dysfunction (AST or ALT
6. Documented use of oral hormonal contraceptives and hormone-releasing implants
7. intolerance or allergy to liraglutide or metformin
Locations (1)
  • Banī Suwayf, Beni Suweif Governorate, Egypt